SOCIOECONOMIC CHARACTERISTICS OF COUNTRIES BASED ON THE PRESENCE OF HTA AGENCY

SOCIOECONOMIC CHARACTERISTICS OF COUNTRIES BASED ON THE PRESENCE OF HTA AGENCY

Background: Broadly defined, health technology assessment (HTA) is the systematic evaluation of medical technologies. This approach takes in to account effectiveness of the technologies, social and ethical aspects and efficiency as well as. A large number of countries globally have not yet implement...

Full description

Bibliographic Details
Main Authors:	Svetlin Georgiev, Antoniya Yanakieva, Stamatios Priftis
Format:	Article
Language:	English
Published:	Peytchinski Publishing 2017-08-01
Series:	Journal of IMAB
Subjects:	HTA Agency Socioeconomic globally
Online Access:	http://www.journal-imab-bg.org/issues-2017/issue3/JofIMAB-2017-23-3p1637-1640.pdf

Similar Items

The role of HTA agencies in Poland and in the world
by: Aneta Katarzyna Mela
Published: (2020-07-01)

HTA CORE MODEL
by: R. I. Yagudina, et al.
Published: (2015-03-01)

HTA nei processi assistenziali e nei modelli organizzativi
by: Lucia Steele
Published: (2019-10-01)

Organizational structure and funding of health technology assessment agencies around the world
by: G. R. Khachatryan, et al.
Published: (2019-07-01)

Expanding HTA – Correcting a Misattribution, Clarifying the Scope of HTA and CEA; Comment on “Ethics in HTA: Examining the ‘Need for Expansion’”
by: Anthony J. Culyer
Published: (2019-12-01)

台灣建立醫藥科技評估（HTA）制度之研究
by: 陳如如, et al.

Improving Interactions Between Health Technology Assessment Bodies and Regulatory Agencies: A Systematic Review and Cross-Sectional Survey on Processes, Progress, Outcomes, and Challenges
by: Richard Ofori-Asenso, et al.
Published: (2020-10-01)

HTA and HIV: The Case of Dual NRTI Backbones in the Italian Setting
by: Elisabetta Garagiola, et al.
Published: (2020-12-01)

Expanded HTA, Legitimacy and Independence; Comment on “Expanded HTA: Enhancing Fairness and Legitimacy”
by: Keith Syrett
Published: (2016-09-01)

A Comparison of Reimbursement Recommendations by European HTA Agencies: Is There Opportunity for Further Alignment?
by: Nicola Allen, et al.
Published: (2017-06-01)

Fair Processes for Priority Setting: Putting Theory into Practice; Comment on “Expanded HTA: Enhancing Fairness and Legitimacy”
by: Maarten P. Jansen, et al.
Published: (2017-01-01)

Ethics in HTA: Examining the “Need for Expansion”
by: Payam Abrishami, et al.
Published: (2017-10-01)

Application of the HTA Core Model for complex evaluation of the effectiveness and quality of Radium-223 treatment in patients with metastatic castration resistant prostate cancer
by: Beata Kiselova Bilekova, et al.
Published: (2018-10-01)

Leveraging EUnetHTA’s conceptual framework to compare HTA decision drivers in France, Italy, and Germany from a manufacturer’s point of view
by: Giovanni Giuliani, et al.
Published: (2018-09-01)

Assessment of Computerized Medical Equipment Management and Maintenance System from HTA perspective: Need and Approach
by: Dr. Nitin Kumar Joshi, et al.
Published: (2021-03-01)

HTA – Algorithm or Process?; Comment on “Expanded HTA: Enhancing Fairness and Legitimacy”
by: Anthony J. Culyer
Published: (2016-08-01)

The Iterative Development of Medicines Through the European Medicine Agency's Adaptive Pathway Approach
by: Giuseppe Nicotera, et al.
Published: (2019-06-01)

Can Health Technology Assessment (HTA) provide a solution to tackle the increasing health-care expenditure in India?
by: Amit Dang, et al.
Published: (2016-01-01)

A random effects model for the identification of differential splicing (REIDS) using exon and HTA arrays
by: Marijke Van Moerbeke, et al.
Published: (2017-05-01)

Imaginary Worlds: The European Network for Health Technology Assessment (EUnetHTA) Recommendations for Health Economic Evaluations
by: Paul C Langley
Published: (2016-08-01)

Expanded HTA: Enhancing Fairness and Legitimacy
by: Norman Daniels, et al.
Published: (2016-01-01)

¿La toma convencional de presión arterial resulta idónea para el diagnóstico y clasificación de Hipertensión Arterial?
by: Nurys B. Armas Rojas, et al.
Published: (2014-02-01)

Strengthening health technology assessment systems in the global south: a comparative analysis of the HTA journeys of China, India and South Africa
by: Kim MacQuilkan, et al.
Published: (2018-01-01)

Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies
by: Pascale Lehoux, et al.
Published: (2017-09-01)

Reimbursement of Orphan Drugs in Europe in Relation to the Type of Authorization by the European Medicines Agency and the Decision Making Based on Health Technology Assessment
by: Krzysztof Piotr Malinowski, et al.
Published: (2018-11-01)

Beyond the Black Box Approach to Ethics! Comment on “Expanded HTA: Enhancing Fairness and Legitimacy”
by: Lars Sandman, et al.
Published: (2016-06-01)

Utilization of multiple-criteria decision analysis (MCDA) to support healthcare decision-making FIFARMA, 2016
by: Julia I. Drake, et al.
Published: (2017-01-01)

DEPISTAREA AMBULATORIE A HIPERTENSIUNII ARTERIALE. STUDIU PRELIMINAR COMPARATIV LA COPII DIN IAŞI ŞI CODLEA
by: Simona Alina Tătaru, et al.
Published: (2010-06-01)

Sink or swim? Responsible situated agency constructed by socioeconomically underprivileged students of English in neoliberal Brazil
by: Carla Janaina Figueredo
Published: (2020-08-01)

A practical application of the Hierarchical Task Analysis (HTA) and Human Error Assessment and Reduction Technique (HEART) to identify the major errors with mitigating actions taken after fire detection onboard passenger vessels
by: de Wolff, L., et al.
Published: (2022)

Quo Vadis HTA for Medical Devices in Central and Eastern Europe? Recommendations to Address Methodological Challenges
by: Rita Daubner-Bendes, et al.
Published: (2021-01-01)

Future of Health Technology Assessment System in Iran: Necessity of reinforcement in both scenarios of sanction’s continuation and its lifting
by: Ali Sarrafkia, et al.
Published: (2021-03-01)

The EU Health Technology Assessment and the Open Method of Coordination: A Relation with Potential in the Context of Network Governance
by: Ani Matei, et al.
Published: (2021-03-01)

Can Standard Health Technology Assessment Approaches Help Guide the Price of Orphan Drugs in Canada? A Review of Submissions to the Canadian Agency for Drugs and Technologies in Health Common Drug Review
by: Balijepalli C, et al.
Published: (2020-08-01)

Assessing the performance of health technology assessment (HTA) agencies: developing a multi-country, multi-stakeholder, and multi-dimensional framework to explore mechanisms of impact
by: Robyn Millar, et al.
Published: (2021-07-01)

Tillbudsrapportering : Ett kognitivt dilemma eller en praktisk svårighet
by: Vaara, Tanja
Published: (2012)

Balanced assessment systems revisited
by: Dávid Dankó, et al.
Published: (2017-01-01)

Comparing access to orphan medicinal products in Europe
by: Bernarda Zamora, et al.
Published: (2019-05-01)

Hyperexpression of TNF-Stimulated 6 (TSG-6) of HumanTracheal Aspirate and Bronchial Alveolar Lavage from Heavy-Smoker and Lung TB
by: Djoko Trihadi
Published: (2011-06-01)

Prediction and Analysis of Human Errors in Operators of Control Rooms at 400 kV Posts and the Effectiveness of the Proposed Measures
by: A.R Haji Hoseini1, et al.
Published: (2012-12-01)